0000899243-22-036729.txt : 20221122 0000899243-22-036729.hdr.sgml : 20221122 20221122163516 ACCESSION NUMBER: 0000899243-22-036729 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221119 FILED AS OF DATE: 20221122 DATE AS OF CHANGE: 20221122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kiboro Ali CENTRAL INDEX KEY: 0001891241 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36415 FILM NUMBER: 221410926 MAIL ADDRESS: STREET 1: C/O QUOTIENT LIMITED, B1 STREET 2: BUSINESS PARK TERRE BONNE CITY: EYSINS STATE: V8 ZIP: 1262 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Quotient Ltd CENTRAL INDEX KEY: 0001596946 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 264719797 STATE OF INCORPORATION: Y9 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA BUSINESS PHONE: 41274832286 MAIL ADDRESS: STREET 1: 28 ESPLANADE CITY: SAINT HELIER STATE: Y9 ZIP: JE2 3QA 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-19 0 0001596946 Quotient Ltd QTNT 0001891241 Kiboro Ali C/O QUOTIENT LIMITED, BUSINESS PARK TERRE BONNE, ROUTE DE CRASSIER 13 EYSINS V8 1262 SWITZERLAND 0 1 0 0 Chief Financial Officer Ordinary Shares 2022-11-19 4 M 0 1526 A 3192 D Restricted Stock Units 2022-11-19 4 M 0 1526 0.00 D Ordinary Shares 1526 1526 D Ordinary Share Option (Right to Buy) 83.20 2031-11-19 Ordinary Shares 3081 3081 D Restricted Stock Units convert into ordinary shares on a one-for-one basis. On November 19, 2021, the Reporting Person was granted 3,052 Restricted Stock Units, of which 1,526 have vested and converted into ordinary shares. The remaining 1,526 will vest in two equal annual installments on November 19, 2023 and November 19, 2024. The Restricted Stock Units were granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4). 1,027 options vested on November 19, 2022 and remain exercisable, and the remaining 2,054 options will vest in two equal annual installments on November 19, 2023 and November 19, 2024. The option was granted as an inducement grant pursuant to Nasdaq listing rule 5635(c)(4). /s/ Ali Kiboro 2022-11-22